계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Royal Emerald Pharmaceuticals
company
About
Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
- 251 - 500
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $16.97M
- Industries
- Alternative Medicine,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$16.97M
Royal Emerald Pharmaceuticals has raised a total of
$16.97M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2022 | Debt Financing | $16.97M | 1 |
Pelorus Equity Group
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Royal Emerald Pharmaceuticals is funded by 1 investors.
Pelorus Equity Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pelorus Equity Group
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
